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We used a gene amplification strategy to analyze T -cell re-
ceptor (TCR) gene rearrangements in 185 specimens, in-
cluding mycosis fungoides/Sezary syndrome (MF ISS), other 
cutaneous neoplasms, inflammatory dermatoses, reactive 
lymphoid tissues, and normal skin. Genomic DNA was ex-
tracted from lesional tissues and rearrangements of the TCR-
y chain gene were amplified using the polymerase chain re-
action (PCR) with primers specific for rearrangements 
involving Vyl-8 or Vy9 gene segments. The resulting PCR 
products were then separated according to their nucleotide 
sequence as well as size by denaturing gradient gel electro-
phoresis (DGGE). Dominant clonal TCR-y gene rearrange-
ments were detected in 61 of 68 MF ISS cases by PCRI 
DGGE. This sensitivity of 90% compared to a sensitivity of 
only 59% when dominant clonality was sought in 17 of these 
same cases by Southern blot analysis of TCR-P gene rear-
rangements. This difference in sensitivity was greatest in 
early, minimally infiltrated skin lesions. PCR/DGGE was 
also more sensitive than Southern blot analysis for detecting 
peripheral blood involvement in two cases of early MF. 
Among 12 additional specimens of suspected MF/SS, nine 
(75%) showed clonal TCR-y gene rearrangements by PCR/ 
DGGE including six of eight cases with a previously con-
firmed diagnosis of MF ISS and three of four cases without 
As in other types of non-Hodgkin'S lymphoma, the diagnosis of mycosis fungoides/Sezary syndrome (MF ISS) [1 - 4) has been aided by the detection of dominant clonal T-cell populations in biopsy speci-mens using Southern blot analysis of T-cell receptor 
(TCR) gene rearrangements [1,5,6). Nevertheless, several features 
of this approach limit its usefulness (7). These limitations include 
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prior known MF/SS. Among 105 non-MF/SS specimens, 
dominant TCR-y gene rearrangements were detected in only 
six cases (6%). Four were diagnosed as chronic dermatitis and 
two were diagnosed as cutaneous lymphoid hyperplasia. 
We conclude that the large majority of MF ISS cases, in-
cluding patch phase disease, possess dominant clonal TCR-Y 
gene rearrangements. PCR/DGGE is more sensitive than 
Southern blot analysis for detecting dominant clonality and 
staging disease in patients with a confirmed diagnosis of MF / 
SS. However, because PCR/DGGE is sensitive enough to 
detect dominant TCR-y gene rearrangements in a subset of 
patients with chronic dermatitis, it cannot be used as the sole 
criterion for establishing a diagnosis ofT -cell lymphoma. As 
with other molecular biologic clonality assays, clinicopatho-
logic correlation is essential. Nevertheless, the detection of 
dominant clonality in some cases of histologically nonspe-
cific dermatitis allows the identification of a previously un-
recognized subset of patients, i.e., those with "clonal derma-
titis." It will be important to determine the long-term risk 
of MF ISS among these patients because our study indicated 
that MF ISS can sometimes present with lesions indistin-
guishable from clonal dermatitis. ] Invest Dermatol1 03:34-
41, 1994 
the requirement for at least 105_106 cells for a single analysis, an 
interval of about one to two weeks necessary to complete the analy-
sis, and frequent reliance on radiolabeled hybridization probes-all 
of which contribute to costs and overall inconvenience. Most im-
portantly, the sensitivity limitations of Southern blot analysis make 
the analysis of lesions containing sparse lymphocytic infiltrates 
problematic because the tumor cell density in' these specimens is 
often too low to ensure against false negative results. 
In an effort to address some of these limitations, various molecu-
lar biologic alternatives to routine Southern blot analysis of TCR 
gene rearrangements have been devised. Many of these methods 
have been reviewed individually elsewhere (7). They generally in-
volve the amplification of TCR-P or TCR-y gene rearrangements 
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using polymerase chain reaction (PCR) techniques. In contrast to 
Southern blot analysis, which utilizes the configuration of 
rearranged V, D, and] gene segments as clonal markers, PCR-based 
methOds utilize nucleotide sequence at the junction of rearranged 
segments as markers of clonality. Unique sequences at these sites are 
created during the process of gene rearrangement due to the combi-
nation of variably sized, small exonucleolytic deletions of germline 
sequences at the ends of the rearranging segments and the insertion 
of short stretches of random nucleotides between the segments prior 
to their joining. The result is a novel sequence specific for an indi-
vidual lymphocyte and any clonal progeny that may derive from 
that cell. 
Although each PCR-based method has certain advantages over 
Southern blot analysis, most possess limitations of their own, in-
volving one or more of the following factors: the need for working 
with RNA, which is more labile than DNA, the need for labor-in-
tensive cloning and sequence analysis ofTCR gene rearrangements, 
and/or the need for radioisotopes and autoradiography. However, 
one method avoids these limitations. This method involves the 
amplification ofTCR-y gene rearrangements followed by the frac-
tionation of the resulting PCR products by denaturing gradient gel 
electrophoresis (DGGE) [8]. The entire procedure has been referred 
to as PCR/DGGE analysis. It involves three main steps: 1) extrac-
tion of genomic DNA from patient specimens, 2) PCR-based am-
plification ofTCR-y gene rearrangements from the genomic DNA, 
and 3) fractionation of the resulting PCR products by DGGE. 
Although in principle applicable to any TCR gene, the TCR-y 
gene is the best target for analysis by PCR/DGGE for several rea-
sons. First, compared to other TCR genes, TCR-y is a relatively 
simple gene, consisting in the germline form of eight V gene seg-
ments, seven V pseudogene segments, and five J segments, of which 
Vy2-Vy5, Vy8-Vyll, ]yl, and ]y2 frequently participate in rear-
rangements [9 -12]. Furthermore, there is enough nucleotide se-
quence homology among various V region a.nd J segments to allo~ 
the design of a small number of consensus pnmers capable of amp It-
fying most TCR-y gene rearrangements [8-12]. Because the Vy 
and ]y target sequences complementary to that of the primers of 
rearranged TCR-y genes are less than 500 bp apart within 
rearranged genes, genomic DNA can be used as the PCR substrate. 
This obviates the need for reverse transcription of mRNA, which 
generally has been used for the PCR-based amplification ofTCR-P 
gene rearrangements because the standard genomic Vp and Cp tar-
get sequences lie too far apart for efficient amplification [7]. 
DGGE was initially developed for the analysis of point mutations 
because it separates double-stranded DNA fragments according to 
nucleotide sequence in addition to size [13-15]. This separation is 
accomplished by electropho~esis of fragments through a gel con-
taining a urea/formamide gradient that results in their partial melt-
ing, and therefore reduced mobility, at a point in the gradient deter-
mined by the nucleotide sequence. If sufficient numbers of 
fragments have identical size and sequence, as is produced by PCR 
of TCR genes from the genomic DNA of a clone of T cells, they 
form a band visible under ultraviolet light after staining of the gel 
with ethidium bromide. On the other hand, heterogeneous frag-
ments, as amplified from polyclonal cells, form only a diffuse smear. 
PCR/DGGE analysis typically requires only 2-3 d to complete, 
and. does not involve radioactive reagents. Standard size cutaneous 
pu:nch and shave biopsy specimens provide adequate tissue for anal-
YSiS. 
In prior studies, it was established that the detection of a domi-
nant clone in tissue specimens by PCR/DGGE correlated with the 
presence of a dominant clone as detected by Southern blot analysis 
[8]. Furthermore, it was shown that PCR/DGGE could detect a 
dominant clone constituting as little as 1.0 - 0.1 % of the total cells 
in the sample [8]. This initial report focused primarily on T-cell 
lines, leukemias, and heavily-infiltrated biopsy specimens of T-cell 
lymphomas. The goal of the current study was to determine the 
utility of PCR/DGGE for the analysis of T-cell clonality specifi-
cally in cutaneous lymphoid infiltrates, to indicate the possible use-
fulness of this procedure for staging tumor distribution in estab-
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lished cases of lymphoma, and for assisting in the diagnosis of cases 
that are difficult to classify as either malignant or benign. Toward 
these ends, we have investigated the prevalence of clonal TCR-y 
gene rearrangements among MF ISS cases, compared the sensitivity 
ofPCR/DGGE to routine Southern blot analysis in a subset of these 
cases, and analyzed the clonality of a wide variety of mflammatory 
cutaneous T-cell infiltrates. 
MATERIALS AND METHODS 
Tissues Representative samples of skin, lymph node, and/or peripheral 
blood mononuclear cells were obtained from 185 cases: 68 patients with 
MF/SS, 12 patients with suspected MF/SS, and 105 patients with other 
diseases. The non-MF/SS specimens all contained lymphoid infiltrates and 
included nonspecific dermatitis (23 cases), cutaneous squamous cell carci-
noma (20 cases), cutaneous basal cell carcinoma (10 cases), cutaneous B-cell 
lymphoma (10 cases), cutaneous lymphoid hyperplasia (nine cases), hyper-
plastic tonsils (three cases), psoriasis (three cases), pityriasis rubra pilaris (two 
cases), acute allergic contact dermatitis (two cases), hyperplastic lymph 
nodes (two cases), herpes zoster (two cases), drug eruptions (two cases), and 
one case each of arthropod reaction, lichenoid keratosis, granuloma annu-
lare, cutaneous cryptococcosis, and cutaneous sinus histiocytosis with mas-
sive lymphadenopathy. Twelve cases of normal skin were also studied. 
These specimens consisted of 4-6-mm cutaneous punch biopsies,S mm X 
10 mm cutaneous shave biopsies, 5-mm3 portions of lymphoid tissue, or the 
mononuclear cells from 20 cm) of blood. These specimens were snap-frozen 
and stored at-70 · C as described previously [16]. In each case, the diagnosis 
was based on established clinicopathologic criteria [1,2). In addition, cryostat 
sections of cases of MF/SS, B-cell lymphoma, and cutaneous lymphoid 
hyperplasia were studied immunohistologically with an extensive panel of 
T-cell, B-cell and histiocytic antigens using a three-stage biotin-avidin im-
munoperoxidase technique as reported previously [16). The minimum panel 
for MF/SS cases included CDla, CD2, CD3, CD4, CDS, CD7, CD8, 
CDllc, CD22, CD30, and K.i67. Some controls, including the epithelial 
neoplasms, were also studied using this antibody panel. MF ISS cases studied 
by Southern blot analysis were also stained additionally with anti - TCR-P 
antibody 8A3. The minimum panel for all other lymphoma and lymphoid 
hyperplasia cases included the MF/SS panel plus CD19, CD20, CD35, and 
immunoglobulin chains (kappa, lambda, mu, delta). In each case studied, the 
immunohistologic findings were characteristic for MF/SS, B-cell lym-
phoma, or cutaneous lymphoid hype.rplasia as described previously [1). In 
addition, all cases of cutaneous lymphoid hyperplasia and cutaneous B-cell 
lymphoma were characterized by Southern blot analysis of immunoglobulin 
heavy-chain gene rearrangements using a J H probe as described previously 
[17). A monoclonal pattern was observed in each case of B-celllymphoma 
but not in any case of lymphoid hyperplasia. 
Southern Blot Analysis of TCR Gene Rearrangements DNA ex-
traction, Southern blot hybridization, and autoradiography were performed 
using standard methods [18) with minor modifications. All MF ISS cases 
subjected to Souther~ blot analysis were studied with a TCR-P probe. Some 
were also studied uSlllg a TCR-y probe. The TCR-P probe consisted of 
combined JP, and JP2 probes. The JP, probe is a 550-bp XbaI fragment 
derived from DNA between the JP, and CPt regions. The JP2 probe is a 
4.3-kb EcoRI DNA fragment containing the JP2 region [19). The TCR-y 
probe is a 2.1-kbp Hi"dm fragment containing the Jy1 region (19). Restric-
~ion enzymes for Southern blo~ a~a1ysis of TCR-P gene rearrangements 
mcluded BgIII and BamHI. R~stnct1on enzymes for Southern blot analysis of 
TCR-y gene rearrangements IIlcluded BgIIl and occasionally Bam HI and/or 
Hit/dIll. 
PCR Genomic DNA (2Ilg) was suspended in PCR buffer containing 40 
pmole of each of two oligonucleotide primers, 200 IlM (each) of the four 
deoxyribonucleoside triphosphates, 50 mM KCI, 10 mM Tris-HCl (PH 
8.3), 1.5 mM MgCI2' 0.01 % gelatin, and 2.5 units Taq DNA polymerase in 
a total volume of 100 III [8). Thermocycling conditions consisted of dena-
turation at 94 · C for 1 min, annealing at 55 · C for 1.5 min, and extension at 
70 · C for 1.5 min. Initially 25 cycles were performed using a set of "outer" 
Vy and Jy consensus primers corresponding to conserved Vy and Jy se-
quences. A 10-1l1 portion. of first-round PCR products in fresh reagent buffer 
was then used as a target III a subsequent round ofPCR using a set of " inner" 
Vy andlyconsensus primers corresponding to conserved Vyand Jy sequences 
nested Il1SI~e the sequence.s complementary to the outer primer pair. The 
outer and Inner pmner pam used for the amplification of rearrangements 
involv~ng VY.1-8 are listed in Table 1. For the amplification of rearrange-
ments mvolvmg Vy9, the outer and IImer Vyl-8 primers were replaced by 
the single Vy9 primer also listed in Table I. First round Vyl-B peR products 
were approximately 480 bp, whereas second round Vyl-8 PCR products 
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Table I. TCR-y Primer Combinations" 
PCR Round Vy Primer Jy Primer 
First round V yl-8 "Outer" Ji' "Outer" 
18 40 68 45 
5' GAA GCT TCT AGC TIT CCT GTC TC 3' 5' CGT CGA CAA CAA GTG TTG TTC CAC 3' 
or 
V y9 
114 135 
5'GGA ATT CCA AAT TCT TGG TTT A 3' 
Second round V y1-8 "Inner" Jy "Inner" 
43 67 52 29 
5' CTC GAG TGC GCT GCC TAC AGA GAG G 3' 5' GGA TCC ACT GCC AAA GAG TIT CTT 3' 
or 
V y9 
' Numbers above nucleotide sequences designate the bp position of the complementary end nucleotides within the target gene. Underlined nucleotides represent restriction 
endonuclease digestion sites as follows: outer V,l-B (Hi"dlII), outer], (SalI), inner V,l-B (XltaI), inner], (Bam HI), V,9 (Eea RI). 
were approximately 420 bp. First- and second-round Vy9 PCR products 
were slightly smaller, measuring about 400 bp and 380 bp, respectively. 
Representative second-round Vy1-8 PCR products are illustrated in Fig 1. 
Selection of optimal primer sequences and PCR conditions including the 
first-roundjsecond-round strategy were determined empirically in prior 
studies using T-cell lines [8]. All PCR reactions in this study were performed 
using a Thermal Cycler (Perkin-Elmer, Norwalk, CT). DNA from each 
specimen was amplified at least twice to ensure that any band detected was 
likely to represent an actual clonal population rather than the chance ampli-
fication of a product from a single cell (81. Negative controls included PCR 
reactions containing all reagents except target DNA. Because our primers 
are specific for VYl-9 and Jyl-2, they do not allow amplification of rear-
rangements involving other TCR-y gene segments such as Vyl0, Vyl1, and 
other Jy segments. 
DGGE DGGE was performed in an apparatus similar to one currently 
available from CBS Scientific Co., Inc. (Del Mar, CA) following procedures 
described by Myers et al (15]. PeR-amplified genomic TCR-y rearrange-
ments were separated by electrophoresis at 60 °C through a 6.5% polyacryl-
amide gel containing a 30-60% ureajformamide denaturing gradient as 
described previously [8). The gels were then stained by immersion in 1 
Jig/ml ethidium bromide for 15 min, after which gels were photographed 
2345678 
Figure 1. TCR-y PCR products. Agarose minigel (1 %) showing typical 
second-round PCR products using the inner Vy1-8 and Jy consensus primer 
pair. A product of about 420 bp is evident as the bright band in lanes 2 - 7. 
Lane 1, carry-over negative control containing all reagents except target 
DNA. Lane 2, lesional skin, lichenoid drug eruption. Lane 3, involved lymph 
node, MF. Lanes 4-6, two skin lesions and peripheral blood mononuclear 
cells, respectively, from one MF patient. Lalle 7, lesional skin, B-ccll lym-
phoma. Lane 8, size markers (Bio Marker Low, Bio Venture, Murfreesboro, 
TN). 
under 300 nm UV light. To eliminate the presence of faint, nonspecific 
bands sometimes noted in prior studies of polyelonal T-cell samples, an 
additional step of melting the PCR products at 95°C for 5 min and then 
reannealing at 60°C for 1 h was introduced prior to loading the samples onto 
the gels (8] . This resulted in diffuse smears without discrete bands in lanes 
containing polyclonal TCR-y PCR products (Fig 2). 
Technical Points Concerning PCR/DGGE Two important technical 
points emerged from these studies. First, cases con taining monoclonal T-cell 
I 2 3456 7 891011121314 
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Figure 2. PCR/DGGE: Polyclonal T-cell pattern. Vy1-8 PCR products 
(lanes 1- 6) and Vy9 PCR products (fatles 7 -13) were subjected to DGGE, 
stained with ethidum bromide, and photographed using UV illumination. 
Lanes 1 - 5 and 7 -12 contain diffuse smears lacking discrete bands. This is 
the typical result in the absence of detectable dominant TCR-y gene rear-
rangements. Lane 1, lesional skin, cutaneous lymphoid hyperplasia. Lane 2, 
lesional skin, B-cell lymphoma. Lanes 3 and 4, lesional skin and reactive 
lymph node, respectively, cutaneous lymphoid hyperplasia. Latle 5, lesional 
skin, cutaneous lymphoid hyperplasia. La/Ie 6, Vyl-8 carry-over negative 
control containing all reagents except target DNA. Lane 7, lesional skin, MF. 
Lanes 8 -1 0, two lesional skin specimens and peripheral blood mononuclear 
cells, respectively, MF . Lanes 11 and 12, two normal skin specimens. Latlt 
13, Vy9 carry-over negative control. Latle 14, empty lane. Although the MF 
specimens were polyclonal for Vy9, they showed dominant clonal bands for 
Vyl-B (for example, see la" e 8 in Fig 3). 
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populations, as evidenced by Southern blot analysis of TCR-/l gene rear-
rangements showing only one or two rearranged bands, can exhibit more 
than cwo discrete bands by PCR/DGGE. Often this appears as one or two 
strong bands and one or more weaker bands. At present, the source of these 
additional weaker bands is unknown; however, they are not due to the fina l 
melting/reannealing step performed prior to loading denaturing gradient 
gels [8]. Some of these bands may be due to heteroduplexes arising from 
annealing together of single strands of DNA amplified from different clonal 
TCR-Y gene rearrangements. More likely, these bands reflect an oligoclonal 
T-cell background from which a dominant T-cell clone has emerged. Be-
cause of possible differences in the lesional density of these clones, only the 
most dominant one may be detectable by Southern blot analysis. Recently, 
we have used elution, cloning, and sequencing to show that the comigrating 
dominant bands present in paired PCR/DGGE analyses of specimens of 
CD30+ large cell lymphoma and lymphomatoid papulosis obtained from a 
single patient do in fact represent a monoclonal TCR-y gene rearrangement 
shared by both lesions [20]. 
Second, although the PCR/DGGE band position produced by a given 
sample is constant in different lanes of the same gel, it can vary somewhat 
among different gels. This is probably due to subtle technical differences that 
can occur with each separate PCR/DGGE analysis. To some degree, this 
issue can be addressed by electrophoresis in each gel of several standard 
fragments. Obviollsly, the best approach to this problem is that specimens to 
be compared should be analyzed side-by-side in the same gel, as represented 
in Fig 3. We found matching dominant clonal band patterns in four MF ISS 
. cases in which multiple specimens were analyzed by PCR/DGGE. 
RESULTS 
Analysis of MF ISS Specimens To determine whether PCRI 
DGGE analysis can reliably detect the presence of dominant T-cell 
clonal populations in skin specimens considered to contain histo-
logic features diagnostic of MF ISS, we analyzed tissues from 68 
cases. Sixty-one of these (90%) showed discrete bands in PCRI 
DGGE analyses including 16 Vyl-8+Vy9+, 35 Vyl-8+Vy9- and 10 
Vyl-8-Vy9+ cases. Examples are illustrated in Fig 3. The presence 
of both Vy1-B and Vy9 rearrangements in a single case is due pre-
sumably to rearrangement of both TCR-y gene alleles. The seven 
specimens that fai led to show discrete bands showed only diffuse 
smears in PCR/DGGE analyses of both Vy1-B and Vy9 rearrange-
ments. 
In 17 of the 68 cases, Southern blot analysis of TCR-{3 gene 
rearrangements was also performed on the same tissues. Representa-
tive Southern blot results are illustrated in Fig 4, and a comparison 
between the results of TCR-y PCR/DGGE and TCR-{3 Southern 
blot analysis is presented in Table II along with details concerning 
the type of specimens analyzed. Dominant c10nality was detected by 
PCR/DGGE analysis in six of seven cases that were negative by 
Southern blotting. Table III compares the false-negative rates for 
these cwo molecular biologic assays in early versus advanced MF I 
SS. These data demonstrate that PCR/DGGE is more sensitive than 
Southern blot analysis for detecting dominant TCR gene rearrange-
ments in early lesional tissues (patches and thin plaques). Specific 
examples are illustrated in Fig 5. 
We chose to compare PCR/DGGE analysis ofTCR-y gene rear-
rangements to Southern blot analysis of TCR-{3 gene rearrange-
ments because Southern blot analysis of TCR- y gene rearrange-
ments can sometimes produce false-positive results [21,22], because 
the TCR-{3 gene is the one that has been studied by Southern blot 
analysis most commonly in the published literature [7] , and because 
almost all cases of MF ISS exhibit TCR-{3 gene rearrangements and 
express the TCR-Q{3 heterodimer [23]. This was also true of the 
cases studied by Southern blot analysis in this series because they 
reacted with anti - TCR-{3 monoclonal antibody 8A3. Southern blot 
analysis of TCR-y gene rearrangements was performed in two of 
these MF JSS cases as well as in two cases each of psoriasis, normal 
skin, and reactive lymphoid tissues, and one case each of granuloma 
annulare and cutaneous B-ceillymphoma. None of these specimens 
exhibited detectable monoclonal TCR-y gene rearrangements. 
Analysis of Suspected MF/SS Specimens In 12 additional 
cases, we performed PCR/DGGE analyses on skin specimens 
judged to contain possible MF ISS but to show features insufficient 
fo r an unequivocal histolo gic diagnosis. Eight of these specimens 
I 234 
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Figure 3. PCR/DGGE: dominant T-cell clonal patterns. Discrete sharp 
bands are present in lanes 1 - 6, 8, 9, 11, 12 and 15. These bands reflect the 
presence of dominant TCR-y gene rearrangements and contrast with the 
diffuse smears present in Fig 2 and in lanes 7, 13, and 16-20, which corre-
spond to the absence of detectable dominant TCR-y gene rearrangements. 
Lanes 1-6, lesional skin (lan es 1-5) and involved lymph node (lane 6) from 
the same Vyl-B+, Vy9+ MF patient. Lanes 1 and 2 show similar results using 
20 pmole versus 40 pmole ofVyl-B primers, respectively. Lanes 3 and 4 show 
similar results using 40 pmole verSllS 20 pmole ofVy9 primers, respectively. 
Lanes 5 and 6 show identical Vyl-B dominant clonal patterns in both lesional 
skin and involved lymph node, respectively. This is consistent with involve-
ment of both specimens by the same T-cell neoplasm. Note, however, that 
the pattern in lanes 1 and 2 is not identical to the pattern in lan es 5 and 6 even 
though similar PCR conditions were used. These differences are due at least 
in part to subtle differences in each DGGE run a11d indicate that it is better to 
compare banding patterns among lanes within the same gel. Latle 7, reactive 
tonsil, Vyl-8-. Latle 8, lesional skin, MF, VyI-B+. Same patient that was 
Vy9- in Fig 2, latle 7. Lane 9, lesional skin, MF, VyI-B+. Lane 10, Vyl -B 
carry-over negative control. Latlc 11, lesional skin, MF, Vy9+. La/Ie 12, 
lesional skin, MF, Vy9+. Latle 13, lesional skin, MF, Vy9-. La/Ie 14, Vyl-B 
carry-over negative control. Latlcs 15 and 16, lesional skin, MF, Vy9+ and 
Vyl-8-, respectively. Latles 17 and 18, lesional skin, B-celilymphoma, Vy9-
and Vyl -8-, respectively. Latles 19 and 20, lesional skin, MF, Vy9- and 
Vyl-8-, respectively. This last case was one of the few MF/SS cases lacking 
both Vyl-B and Vy9 dominant clonal patterns. 
came from patients with a prior confirmed diagnosis of MF/SS. 
Whether or not there was a prior diagnosis of MF ISS, there was a 
strong correlation between dominant clonality and histology suspi-
cious for MFjSS. Dominant clonality was found in 75% of these 
patients (six of eight) with a history of MF ISS, and in the same 
percentage of these patients (three of four) without a history of 
MF/SS. 
In four of the cases with prior MF JSS, diagnostic specimens con-
taining neoplastic T cells (blood in three cases and a skin tumor in 
the fourth) were available for comparison with the non-diagnostic 
specimen from the same case. PCRjDGGE showed similar bands in 
the paired diagnostic specimens in three of these cases. The fourth 
showed discrete bands in both specimens of the pair (skin patch and 
tumor), although the bands were found in different positions within 
the gel. The precise explanation for this phenomenon is obscure, 
but changes in clonal TCR-y gene rearrangements over time have 
been observed in cases of aCllte lymphoblastic leukemia. In this 
situation, such changes have been attributed to derivation of the 
leukemia from a transformed lymphocytic precursor, with subse-
quent rearrangement of TCR- y genes in progeny ceJls [17]. 
Overall, these cases demonstrated that in patients with a past 
history of MF ISS, the disease can recur as a clonal, histologically 
nondiagnostic, cutaneous T-cell infi ltrate. These cases also sug-
38 WOOD ET AL 
2 3 4 5 6 7 8 9 10 II 
• 
Figure 4. ~outhern blot analysis ofTCR-P gene rearrangements in some of 
the MF cases illustrated in Fig 3. One or two rearranged bands (arrowheads) 
are present in each lane consistent with the presence of a monoclonal T-cell 
population in each case. Unmarked germline bands are also present in each 
lane. BamHI germline band is approximately 23 kb. BglII germline bands 
cluster around 9 kb. The number of germline bands in BglII digests varies 
because of a polymorphism in the number of restriction sites. Lanes 1- 4, 
same case as in Fig 3, lalles 1- 6. Lanes 1 and 2 are BglII digests of skin and 
lymph node, respectively. Lalles 3 and 4 are BamHI digests of skin and lymph 
node, respectively. LOlles 5 and 6, BglII and BamHI digests, respectively, of 
the same case as in Fig 3, lane 8. Larles 7 and 8, BglII and BatnHI digests, 
respectively, of the same case as in Fig 3,Iatle 9. Lanes 9 and 10, BglII and 
BatllHI digests, respectively, of the same case as in Fig 3,Ialles 15 and 16. LOlle 
11 , Bglii digest of same case as in Fig 3,IatJes 19 and 20. This last case was the 
only one in our series that showed dominanr clonality by Southern blot 
analysis ·but not by PCR/DGGE. 
gested the possibility that patients without a prior diagnosis of MF / 
SS could present initially in this same way. Serial studies of one of 
the MF ISS cases provided confirmatory evidence for this possibil-
ity. This patient (initials J.I.) underwent autologous bone marrow 
transplantation for Hodgkin's disease and subsequently developed 
generalized, sometimes erythrodermic, cutaneous T-cell infiltrates 
containing a dominant clone detectable by PCR/DGGE but not by 
Southern blot analysis. One percent Sezary cells were later identi-
fied in this patient's peripheral blood. Initial skin biopsies were 
interpreted as nonspecific, chronic spongiotic dermatitis. Although 
some subsequent skin biopsies were suggestive of MF/SS, they re-
mained histologically nondiagnostic. Nevertheless, they all con-
tained an infiltrate of CD4+ T cells, the majority of which were 
CD5- and CD7-. This phenotype is consistent with MF ISS but not 
inflammation [1,5]. Furthermore, the dominant clonality pattern 
was consistent in multiple skin specimens. Based on these findings, 
we concluded that this patient had early MF/SS that presented as a 
clonal, cutaneous T-cell infiltrate indistinguishable histologically 
Table II. Results of TCR-/, PCR-DGGE and TCR-fi Southern 
Blot Analysis as a Function of Specimen Type in MF/SS' 
TCR-P Southern Blot PCR/DGGE+ PCR/DGGE- Total 
Positive 9(lB,lT,5Q,2P) l(Q) 10 
Negative 6(lT,lQ,4P) l(P) 7 
Not done 46(5B,10T,31P) 5(2B,3P) 51 
Total 61 7 68 
·B, leukemic blood; T, cutaneous tumor; Q. cutaneous thick plaque; P, cutaneous 
patch/thin plaque. 
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Table III. False Negative Rates for TCR-/, PCR/DGGE and 
TCR-fi Southern Blot Analysis in Early versus Advanced MF/SS 
Method 
PCR/DGGE 
Southern Blot 
Early MF/SS' 
1/7 (14%) 
5/7 (71%) 
-Patches or thin plaques. 
False Negative Rate 
Advanced MF /SSb 
1/ 10 (10%) 
2/10 (20%) 
'Thick plaques, tumor, or leukemic blood. 
Total 
2/17 (12%) 
7/17 (41 %) 
from nonspecific dermatitis. Because patients with lymphomatoid 
papulosis, a clonal, clinically benign disorder, are at increased risk 
for MF/SS and Hodgkin's disease [1,24,25]' it was not unexpected 
to observe an association between overt lymphomas and this clonal, 
nonspecific dermatosis. Although this patient's skin lesions cleared 
transiently in response to total skin electron beam radiation therapy, 
they recurred and proved refractory to subsequent topical and sys-
temic therapy. The patient eventually died of sepsis. An autopsy was 
not performed. 
Molecular Biologic Staging ofMF ISS by PCR/DGGE Anal-
ysis In addition to the information regarding tumor clone distri-
bution obtained by PCR/DGGE analysis of multiple skin speci-
mens as discussed above, we also studied extracutaneous tissues in 
four MF ISS cases. The peripheral blood of two stage Ib MF patients 
contained low numbers of circulating atypical lymphocytes but no/ 
rare Sezary cells. TCR-fi and TCR-y Southern blot analysis of these 
blood specimens were negative; however, both specimens were 
clonal by PCR/DGGE. A third patient with stage Ib MF and a 
cytologically normal peripheral smear lacked evidence of blood in-
1 23 456 
Figure 5. Southern blot analysis showing an absence of detectable TCR-P 
gene rearrangements in MF cases that showed dominant TCR-y gene rear-
rangements by PCR/DGGE. Lalle 1, negative Southern blot analysis of 
lesional skin from patch-type MF (TCR-P probe, BglII digest). La.les 2 and 3, 
PCR/DGGE analysis of the same case as in lalle 1 shows a Vyl-8- pattern in 
morphologically normal peripheral blood (Ialle 2) and a Vy1-8+ pattern in 
the same skin specimen as in lane 1 (Ialle 3). Lalle 4, negative Southern blot 
analysis of lesional skin from a MF tumor nodule (TCR-P probe, BglII 
digest). Latles 5 and 6, PCR/DGGE analysis of the same specimen as in lane 4 
shows Vyl-S+ and Vy9- patterns, respectively. The difference in the number 
of germ line bands visible in lalles 1 and 4 is due to a polymorphism in the 
presence of Bg/II restriction sites. 
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volvement by PCR/DGGE although her cutaneous MF patch le-
sions were positive. Similarly, a cytologically normal lyn:Ph node 
removed from a patient with stage Ia MF also lacked eVidence of 
involvement by PCR/DGGE although her cutaneous MF patches 
showed dominant clonality. 
Analysis ofNoo-MF ISS SpeciIneos To determine the clonal-
. ty ofTCR-y gene rearrangements in non - T -cell lymphoma speci-
:Uens we used PCR/DGGE to analyze the 105 biopsies of inflam-
matory dermatoses, cutaneous B-cell lymphoma, normal skin, and 
reactive lymphoid tissues listed in Materials and Methods. In the vast 
majority of cases (94%), Vyl-8 and Vy9 PCR l?roducts produced 
only a diffuse smear after DGGE, consistent With the absence of 
dominant T-cell clonal populations bearing Vyl-9/Jyl-2 rear-
rangements in these samples (Fig 2). This included the cases of 
cutaneous squamous cell carcinoma and basal cell carcinoma se-
lected for study based on the presence of a significant T-cell host 
response as assessed by immunohistology. . 
Occult dominant TCR-y gene rearrangements were detected III 
only six specimens, including four cases of nonspecific dermatitis 
(hereafter referred to as "clonal dermatitis") and two cases of cuta-
neoUS lymphoid hyperplasia (hereafter referred to as "clonal cuta-
neous lymphoid hyperplasia"). The nonspecific dermatitis group 
contained 23 cases characterized histopathologically by a superficial 
perivascular lymphocytic in~ltrat~ accompanied in ~ost cases .by 
variable degrees of spongiOSIS, epidermal hyperplaSia, and/or 111-
flammation at the epidermal-dermal interface. Overall, this derma-
titis group contained one case with clonal Vyl-8 rearrangements 
and three cases with clonal Vy9 rearrangements. The cutaneous 
lymphoid hyperplasia group contained nine cases, incl~ding one 
case with clonal Vyl-8 rearrangements and one case With clonal 
Vy9 rearrangements. 
In the six cases of clonal dermatitis and clonal cutaneous lymph-
oid hyperplasia, the Vyl-8 and Vy9 PCR pro.ducts formed repro-
ducible discrete bands after DGGE; however, 111 a number of these 
cases, the bands obtained from Vy9 PCR products were rather faint. 
In general, amplification with the Vy9 primer is more likely to 
produce artifactual bands of low intensity because the number of 
TCR-y gene rearrangements containing a Vy9 segment in a poly-
clonal population of T cells will be fewer than those containing 
Vyl-8 segments. Consequently, a TCR-y gene rearrangement 
present in only one copy may conceivably amp~i~ to prod.uce a 
visible band in the gel. On the other hand, the ablhty to obtam the 
same faint bands in multiple amplifications of DNA from the 
present specimens suggests that this is not a sufficient explanation 
and the bands observed do arise from dominant T cells clones in the 
tissues. 
DISCUSSION 
In this study, we used PCR/DGGE analysis to determine the clonal-
ity of T cells in samples obtained from 185 individuals including 
105 non- T-cell lymphoma patients representing a wide variety of 
diagnoses, 68 patients with MF ISS, and 12 patients with suspected 
MF/SS. Our findings indicate that the large majority of MF/SS 
cases (90%) contain clonal TCR-y gene rearrangements involving 
Vy1-9 and Jyl-2. Only seven of 68 MF/SS cases (10%) lacked 
detectable dominant clonal TCR-y gene rearrangements. Presum-
ably these cases contained TCR-y rearrangements involving Vy 
genes not detectable with our primers, previously deleted Vyl-9 
rearrangements, or germline TCR-y genes. Because there are at 
least two other known TCR-y V segments (Vyl0 and Vy11) [11], it 
is probable that the future use ofPCR primers capable of amplifying 
rearrangements of these other Vy segments will result in an overall 
sensitivity exceeding the current 90% level. Use of primers to other 
Jy genes (JyP, JyP1 , and JYP2) may also increase the yield of positive 
results, although prior studies suggest that many TCR-y gene rear-
rangements in T-cell neoplasms involve Jy1 or Jy2, which are both 
detected by our Jy consensus primers [8-11]. The relatively large 
proportion of MF/SS cases containing dominant TCR Vy9 gene 
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rearrangements may be explained at least in part by the apparent 
preferential generation and selection of TCR-y gene rearrange-
ments involving 3' V region genes such as Vy9 [26,27]. This may 
also explain the predominance of dominant TCR Vy9 gene rear-
rangements among the six cases of clonal non-MF ISS specimens. It 
should be noted that despite negative findings in our cases of cuta-
neous B-cell lymphoma, the detection of dominant clonal TCR-y 
gene rearrangements cannot be used to infer T-cell lineage because 
some B-cell neoplasms can exhibit clonal TCR-y gene rearrange-
ments [11]. 
In this series of cases, which included mostly early skin lesions 
containing relatively sparse infiltrates, PCR/DGGE was considera-
bly more sensitive than Southern blot analysis for detecting domi-
nant clonal TCR gene rearrangements in early MF ISS. Comparable 
levels of sensitivity for detecting clonality in MF/SS have been 
described in preliminary reports by others using related methods 
[Staib G, Mielke V, Griesser H, Menke M, Duller B, Sterry W: 
PCR-analysis ofT-cell-receptor (TCR)-y genes to differentiate be-
tween malignant and reactive T-cell infiltraters of the skin (abstr). 
] Invest Dermatol 100:458, 1993; van Oostveen JW, Bakels V, 
Meijer CJLM, Willemze R: Comparisons of Southern blot and 
PCR/DGGE T-cell receptor gene rearrangement analysis in the 
diagnosis of cutaneous T -lymphoma (abstr). ] Invest Dermatol 
100:448,1993; Greiner TC,Jaffe E: analysis of clonal TCR gamma 
gene rearrangements in paraffin embedded T cell lymphoid neo-
plasms by denaturing gradient gel electrophoresis of GC clamped 
PCR products (abstr). Lab Invest 68:91,1993]. Consequently, PCR/ 
DGGE has considerable value as a backup assay for lymphoma spec-
imens that are negative by Southern blot analysis. As detailed in 
Table II, six of 17 MF ISS cases studied by both Southern blot and 
PCR/DGGE were shown to contain dominant T-cell clones only 
by PCR/DGGE. In many of these cases, the specimens analyzed 
were minimally infiltrated lesions characteristic of early disease 
(Tables II and III). These findings indicate that PCR/DGGE will be 
superior to Southern blot analysis for staging MF ISS patients and 
monitoring their response to therapy. This conclusion is also sup-
ported by the ability of PCR/DGGE to identify the MF ISS domi-
nant clonal pattern in histologically equivocal specimens from 
known MF/SS patients and its superior sensitivity in our initial 
staging investigations. 
In addition, these findings are consistent with the view that his-
tologically recognizable patch-type MF is a monoclonal disorder. 
They suggest that the failure of Southern blot analysis to detect 
monoclonality in some prior studies of patch-type MF [28,29] was 
due to the limited sensitivity of this technique rather than to the 
absence of a monoclonal tumor cell population within the lesions. 
The increased sensitivity ofPCR/DGGE analysis relative to South-
ern blot analysis may derive both from its applicability to smaller 
absolute numbers of lymphocytes and from its ability to detect a 
clonal fraction of lymphocytes about tenfold lower than Southern 
blotting [8]. 
Our current data also offer insights into the clonality of T-cell 
populations in normal skin, reactive lymphoid tissues, a wide vari-
ety of inflammatory dermatoses, and the host response to tumors. In 
the vast majority of these non-MF/SS specimens (99 of 105 or 
94%), we were able to detect only polyclonal TCR-y gene rear-
rangements, supporting the polyclonal nature of T cells in these 
samples. Nevertheless, six of our 105 non- T-cell lymphoma speci-
mens (6%) contained evidence of dominant T -cell clonality. It is 
possible that the detection of discrete bands by PCR/DGGE in 
these six cases might have arisen from the fortuitous amplification 
of TCR-y genes in over-represented reactive T-cell clones; how-
ever, it is also possible that the dominant TCR-y gene rearrange-
ments in some or all of these cases originated in occult neoplastic 
clones. It is noteworthy that the six clonal non-MF/SS cases were 
restricted to two general disease categories: nonspecific dermatitis 
(four cases) and cutaneous lymphoid hyperplasia (two cases). We 
felt it was important to study both of these disease categories because 
early MF/SS is sometimes difficult to distinguish from chronic der-
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matitis, and other cutaneous lymphomas are sometimes difficult to 
distinguish from cutaneous lymphoid hyperplasia [1-4J. 
A subset of cutaneous lymphoid hyperplasia cases have been 
shown previously to contain occult dominant B-cell or T-cell clones 
[1,30- 34], and it is known that clonal TCR-y gene rearrangements 
can be present in both B-cell and T-cell lymphoma [1,5-7,11]. 
Therefore, it is possible that the two clonal cases of cutaneous 
lymphoid hyperplasia each harbored an occult neoplastic B-cell or 
T-cell clone bearing a TCR-y gene rearrangement. Several studies 
have now documented cases in which clonal cutaneous lymphoid 
hyperplasia has evolved into overt lymphoma, predominantly of 
B-cell type [1,30- 32,34]. Furthermore, these same studies indicate 
that patients with clonal cutaneous lymphoid hyperplasia represent 
a recognizable subgroup that is at increased risk for the development 
of cutaneous B-celllymphoma. 
In addition to clonal cutaneous lymphoid hyperplasia, there are 
other situations in which a clinically benign clonal disease has been 
associated with an increased risk of overt lymphoma. These include 
other forms of extranodal lymphoid hyperplasia, the so-called be-
nign monoclonal gammopathies, lymphomatoid papulosis and 
angioimmunoblastic lymphadenopathy with dysproteinemia 
[24,25,35-37]. This relationship between clonal B-cell and T-cell 
processes and increased lymphoma risk suggests that patients with 
clonal dermatitis may also repre~e~t a subgroup that is at i~crea~ed 
risk for the development of chmcally overt lymphoprohferattve 
disorders such as MF ISS . This conclusion is supported by our data, 
which showed that previously undiagnosed MF ISS can present as 
apparent clonal dermatitis (see case ].1. above), and that a strong 
correlation exists between dominant c10nality and histologic fea-
tures suspicious for MF ISS. This conclusion is also consistent with 
numerous anecdotal reports of MF ISS developing at sites of appar-
ent chronic dermatitis [3,41. It is these observations that may ac-
count in part for the difficulty pathologists have encountered in 
developing minimal morphologic criteria for the diagnosis of early 
MF ISS, and the relatively high level of inter- and intra-observer 
variability involved in early MF ISS diagnosis [1,2,381. When con-
sidering the potential neoplastic significance of clonal dermatitis, it 
is also important to note that non-neoplastic lesions of allergic con-
tact dermatitis, induced in two patients with active MF, did not 
contain dominant TCR-y gene rearrangements detectable by PCRI 
DGGE although their MF lesions did [Veelken H, Sklar}, Wood 
GS: Presence of malignant T cells in lesions of allergic contact 
dermatitis developing in patients with cutaneous T cell lymphoma 
(abstr). Immutlobio/186:152, 1992]. 
In summary, our findings demonstrate that clonal TCR-y gene 
rearrangements are present in the large majority of MF ISS patients. 
This indicates that MF ISS is a clonal disorder even in its earliest 
recogniz.able phases. Furthermore, PCR/DGGE is more sensitive 
than Southern blot analysis ofTCR gene rearrangements for detect-
ing dominant clonality and staging disease in patients with con-
firmed MF/SS. However, because PCR/DGGE is sensitive enough 
to detect clonal TCR-y gene rearrangements in a subset of patients 
with chronic dermatitis, it cannot be relied upon as the sole criterion 
for establishing an unequivocal diagnosis of T -cell lymphoma. As 
with other molecular biologic assays oflymphoid clonaIity, clinico-
pathologic correlation is essential. Nevertheless, the detection of 
dominant clonality in some cases of histologically nonspecific der-
matitis allows the identification of a previously unrecogniz.ed subset 
of patients, i.e., those with "clonal dermatitis." It will be important 
to determine the long-term risk of MF ISS among these patients 
because our study indicates that MF ISS can sometimes present as 
apparent clonal dermatitis. C lose follow-up of these patients could 
allow the diagnosis oflymphoma to be made at the earliest possible 
time. This is important because some studies have suggested that 
appropriate therapy initiated early in the course of MF/SS may 
improve not only the initial complete response rate but also long-
term freedom from relapse and possibly the chances for cure [39-
41]. Furthermore, early stage of disease at the time of diagnosis is a 
consistently favorable prognostic variable associated with longer 
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median survival regardless of the specific type of treatment given 
[39-41]. 
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ERRATA 
In the April issue, in the Review by Francesco Sinigaglia (Sinigaglia F: The molecular basis of 
metal recognition by T cells.] Irlllest Dermatoll02:398 - 401, 1994) under the heading Metal 
R ecognition by T Cells Is MHC R estricted, the fourth sentence should read "The results were clear: 
the clones responded to the nickel in association with HLA-DRw11 [7] and to gold in associa-
tion with DR1 [9] or DR4 {Romagnoli P, Sinigaglia R, unpublished)." 
Also in that issue, in the report by Amagai et al {Amagai M, Karpati S, Klaus-Kovtun V, 
Udey Me, Stanley JR: Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) 
mediates weak homophilic adhesion.] Invest D ermato/102:402 - 408, 1994), the next to last 
sentence of the third paragraph should read "O'-catenin, on the other hand, is the most loosely 
associated with the cadherin-catenin complex and is sometimes difficult to detect [13,15] ." and 
the first sentence of the following paragraph should read "The cytoplasmic tail ofpV A, like the 
other desmogleins, binds only to plakoglobin (which co-migrates on sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-P AGE) with O'-catenin, but is probably a distinct 
protein [17,10]) and does not bind to 0'- or j1-catenin [19]." 
